Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCH346 in Early Parkinson's Disease
NCT00407212Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2002
- Primary completion
- Nov 2003
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of omigapil in Parkinson's disease (PD), sponsored by Novartis. Started Jan 2002; status: completed.
02
Drugs
omigapil
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00407212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407212.